News | December 28, 2024
Sterling Biotech and Zydus Lifesciences agree to extend completion of business transfer
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Divestment is part of BASF’s strategic portfolio optimization
The company has received the GMP Certification after successful closure of the inspection
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Final decision from the European Commission is anticipated within the coming months
First and only PARP inhibitor to improve overall survival in early breast cancer
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
Subscribe To Our Newsletter & Stay Updated
